Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
about
Emerging roles for intersectin (ITSN) in regulating signaling and disease pathwaysMouse pulmonary adenoma susceptibility 1 locus is an expression QTL modulating Kras-4ARAS oncogenes: weaving a tumorigenic webAllelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis.The structural basis for cancer treatment decisions.Decreased tumorigenesis in mice with a Kras point mutation at C118Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus.The mutational landscapes of genetic and chemical models of Kras-driven lung cancerK-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motifKRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations.Drugging the undruggable RAS: Mission possible?Rare codons capacitate Kras-driven de novo tumorigenesis.Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer.RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally.Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration.Absolute Quantification of Endogenous Ras Isoform AbundanceDuctal activation of oncogenic KRAS alone induces sarcomatoid phenotypeA New View of Ras Isoforms in Cancers.Tissue-specific tumorigenesis: context matters.Roles of palmitoylation and the KIKK membrane-targeting motif in leukemogenesis by oncogenic KRAS4AInteractions between wild-type and mutant Ras genes in lung and skin carcinogenesis.Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progressionTPL2 kinase is a suppressor of lung carcinogenesisSos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis.Comparison of liver oncogenic potential among human RAS isoforms.How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.Endogenous expression of Hras(G12V) induces developmental defects and neoplasms with copy number imbalances of the oncogeneThe genetics and biology of KRAS in lung cancer.Prevalence of driver mutations in non-small-cell lung cancers in the People's Republic of China.Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer.K-ras 4A and 4B mRNA levels correlate with superoxide in lung adenocarcinoma cells, while at the protein level, only mutant K-ras 4A protein correlates with superoxideThe renewed battle against RAS-mutant cancers.miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.The role of wild type RAS isoforms in cancer.Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation.Metabolic rewiring in mutant Kras lung cancer.RAS Proteins and Their Regulators in Human Disease.Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivoImproving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.Rare codons regulate KRas oncogenesis.
P2860
Q26824407-28F3207F-8481-4F39-901D-E2ECCF275121Q27316056-6FCC9C7A-53CC-449B-851E-1A410CE7A9E9Q28250360-92782B8E-0E6E-4D0E-8AED-E88D916BDEBCQ33687066-8CB17C34-74E2-4D81-82A3-EFBEE0E84D28Q34365654-99203FFF-E24C-41BC-8DD6-D7803B2341FAQ34523367-C317E3BB-FB53-40C0-9696-F6B3F679FE87Q34667782-238BEE41-41E4-4B82-B57C-CD01C2A003CFQ35007114-E35D101D-0FE7-4496-B801-21171D42EF33Q35031435-3A8F085D-E505-4A49-853F-D8A7353D12BDQ35083740-9B5243EE-419F-4868-84FE-E4D9186057EDQ35163434-E1C256ED-88FF-4030-AFD0-89ACFF985591Q35242568-EFA40373-F541-4753-94E4-AF66DA975F0EQ35387532-ED098ABB-5F61-47B5-8DA0-1D5B1D87916CQ35683647-9F38F678-1FEB-4C9E-95A5-539306206383Q35830233-5ABA8D4E-CC1A-4D81-945B-E6732C325AC5Q35839061-D7E3EB3E-9144-4BA0-814C-5AA14DC7AC38Q36273532-D28C92CB-F745-432A-8000-ED6B95F397FEQ36278636-59BB06C8-6B0D-45CB-8C08-2D2238B35F83Q36296335-EFD9AEC9-FA53-4593-9032-E028898302B3Q36416861-C34EAC0A-49B0-45EE-887A-FE84C3DAC78BQ36448966-A4A8A25D-821F-4976-88EF-7320A376FEE1Q36678062-72C178E5-FEA8-4F8F-A302-84F3B57D75ABQ36781882-218BB13C-C45E-46A1-9D9E-D3DD4E07F255Q36808753-1522134F-7EE8-42D4-8EC0-340A1DA3861DQ36916485-AAE78760-2E63-4DDF-A676-4E5F3BCE83CFQ37113976-AB9FF377-C8F3-4EAC-AAFA-5BA29A103009Q37173658-A2B839CC-9BF4-44CE-B652-F19800CF258DQ37354111-A84F02F1-9F69-4121-AF3C-804E22008F14Q37566819-E7795720-088A-4911-9F4A-EE9DD0781CAEQ37610817-207E7D30-BCE7-4C54-AE3E-CE9DBDF39879Q37712302-4A21CE62-895F-40FA-B132-C607A107B12BQ38740000-6795D9AC-CB86-4C74-9122-165749CDC0D3Q38819406-05964A85-F648-449A-AE35-A7ADBDE11CF0Q38898397-6BAE07CB-65DF-49CF-8D01-850248835A42Q39144248-0660CABF-9778-42E3-A026-A02CFC0ADC04Q39343660-BE64B854-657E-472F-8788-7CC05FD4AF7FQ39407402-AC78CA15-E0E7-4950-8EB4-122D5716DCCAQ39437873-9CDE42A3-B39B-4B4A-B3A4-D11EDDFDBC38Q42545098-A4FDDF0A-3421-45FD-8995-1F7965CF5260Q43220010-00FC66E8-43C2-4C7F-B393-93721AC2E216
P2860
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
@en
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
@nl
type
label
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
@en
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
@nl
prefLabel
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
@en
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
@en
P2093
Allan Balmain
Anthony N Karnezis
Christine E Wong
Reyno Del Rosario
Roberto Di Lauro
P2860
P2888
P304
P356
10.1038/NG.211
P407
P577
2008-08-31T00:00:00Z
P5875
P6179
1018799027